Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
<p><strong>Objectives</strong> In treat to target (T2T), the patient is treated to reach and maintain specified and sequentially measured goals, such as remission or low disease activity. T2T in psoriatic arthritis (PsA) has demonstrated improved clinical and patient-reported outco...
Main Authors: | Dures, E, Taylor, J, Shepperd, S, Mukherjee, S, Robson, J, Vlaev, I, Walsh, N, Coates, LC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2020
|
Similar Items
-
Treat-to-target in PsA: methods and necessity
by: Dures, E, et al.
Published: (2020) -
What should be the primary target of "treat to target" in psoriatic arthritis?
by: Coates, LC, et al.
Published: (2018) -
Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
by: Coates, L, et al.
Published: (2022) -
Novel concepts in psoriatic arthritis management: Can we treat to target?
by: Tucker, L, et al.
Published: (2018) -
Psoriatic Arthritis Priority Setting Partnership: patient and clinician informed considerations for future UK health service delivery
by: James, L, et al.
Published: (2024)